Carmell’s Plasma-based Bioactive Materials (PBMs) utilize the entire content of the platelet enriched plasma, allowing for higher total product yields and retention of valuable regenerative factors native to platelets and plasma. The final materials are safe, available as off-the-shelf products with low lot-to-lot variability, formable at the time of manufacturing into variety of complex, 3D shapes, biodegradable and can be fine-tuned to breakdown and release active biologics over different periods of time (days, weeks, months).
All Carmell’s products will utilize the same drug substance. The drug substance has been reviewed by the FDA as part of the IND for a late-stage study for accelerated healing in severe tibia fractures.